Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa - Hughes, D A; Elliott, P M; Shah, J (Heart, 2008)
et al.